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Abstract: Large-scale grid infrastructures for in silico drug discovery open 
opportunities of particular interest to neglected and emerging diseases. In 2005 
and 2006, we have been able to deploy large scale in silico docking within the 
framework of the WISDOM initiative against Malaria and Avian Flu requiring 
about 105 years of CPU on the EGEE, Auvergrid and TWGrid infrastructures. 
These achievements demonstrated the relevance of large-scale grid 
infrastructures for the virtual screening by molecular docking. This also 
allowed evaluating the performances of the grid infrastructures and to identify 
specific issues raised by large-scale deployment. 
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1 Introduction 
In silico drug discovery is one of the most promising strategies to speed-up the drug 
development process [1]. Virtual screening is about selecting in silico the best 
candidate drugs acting on a given target protein [2]. Screening can be done in vitro 
but it is very expensive as there are now millions of chemicals that can be synthesized 
[3]. A reliable way of in silico screening could reduce the number of molecules 
required for in vitro and then in vivo testing from a few millions to a few hundreds.
 In silico drug discovery should foster collaboration between public and private 
laboratories. It should also have an important societal impact by lowering the barrier 
to develop new drugs for rare and neglected diseases [4]. New drugs are needed for 
neglected diseases like Malaria where parasites keep developing resistance to existing 
drugs or Sleeping sickness for which no new drug has been developed for years. New 
drugs against Tuberculosis are also needed as the treatment now takes several months 
and is therefore hard to manage in developing countries. 
 However, in silico virtual screening requires intensive computing, of the order of a 
few TFlops per day to compute 1 million docking probabilities or for the molecular 
modelling of 1,000 ligands on one target protein. Access to very large computing 
resources is therefore needed for successful high throughput virtual screening [5]. 
Grids now provide such resources. A grid infrastructure such as EGEE [6] today 
provides access to more than 30,000 computers and is particularly suited to compute 
docking probabilities for millions of compounds. Docking is only the first step of 
virtual screening since the docking output data have to be further processed [7]. 
 This paper will present the context and objectives of the two initiatives against 
Malaria and avian flu in chapters 2 and 3. In chapter 4, the grid infrastructures and the 
environments used for large-scale deployment are briefly described. Results and 
performance of grid environment are discussed in chapter 5. In chapter 6, we will 
also propose some perspectives for the coming years. 
2 Large scale in silico docking against Malaria 
Genomics research has opened new ways to find novel drugs to cure Malaria, 
vaccines to prevent Malaria, insecticides to kill infectious mosquitoes and strategies 
to prevent development of infectious sporozoites in the mosquito [8]. These studies 
require more and more in silico biology. Grid computing supports all of these steps 
and, moreover, can also contribute significantly to the monitoring of ground studies to 
control Malaria and to the clinical tests in plagued areas.   
 A particularly computing intensive step in the drug discovery process is virtual 
screening which is about selecting in silico the best candidate drugs acting on a given 
target protein. Screening can be done in vitro using real chemical compounds, but this 
is a very expensive not necessarily error-free undertaking. If it could be done in silico 
in a reliable way, one could reduce the number of molecules requiring in vitro and 
then in vivo testing from a few millions to a few hundreds. 
 The WISDOM [9,10] experiment ran on the EGEE grid production service during 
summer 2005 to analyze one million drug candidates against Plasmepsin, the aspartic 
protease of Plasmodium responsible for the initial cleavage of human haemoglobin. 
2.1 Grid Objective 
A large number of applications are already running on grid infrastructures. Even if 
many have passed the proof of concept level [11], only few are ready for large-scale 
production with experimental data. Large Hadron Collider experiments at CERN, like 
the ATLAS collaboration [12], have been the first to test a large data production 
system on grid infrastructures [13]. In a similar way, WISDOM aimed at deploying a 
scalable, CPU consuming application generating large data flows to test the grid 
infrastructure, operation and services in very stressing conditions. 
 Docking is typically an embarrassingly parallel application, with repetitive and 
independent calculations. Large resources are needed in order to test a family of 
targets, a significant amount of possible drug candidates and different virtual 
screening tools with different parameter / scoring settings. This is both a 
computational and data challenge problem to distribute millions of docking 
comparisons with millions of small compound files. 
Moreover, docking is the only application for distributed computing that has 
prompted the uptake of grid technology in the pharmaceutical industry. The 
WISDOM scientific results are also a means of making a demonstration of the EGEE 
grid-computing infrastructure for the end users community, of illustrating the 
usefulness of a scientifically targeted Virtual Organization, and of fostering an uptake 
of grid technologies in this scientific area. 
2.2 Biological objective 
Malaria is a dreadful disease caused by a protozoan parasite, plasmodium. A new 
strategy to fight Malaria investigated within WISDOM aims at the haemoglobin 
metabolism, which is one of the key metabolic processes for the survival of the 
parasite. Plasmepsin, the aspartic protease of Plasmodium, is responsible for the 
initial cleavage of human haemoglobin and later followed by other proteases [14]. It 
is an ideal target for rational drug design against Malaria. 
 Docking is a first step for in silico virtual screening. Basically, protein-ligand 
docking is about estimating the binding energy of a protein target to a library of 
potential drugs using a scoring algorithm. The target is typically a protein, which 
plays a pivotal role in a pathological process. The goal is to identify which molecules 
could dock on the protein active sites in order to inhibit its action and therefore 
interfere with the molecular processes essential for the pathogen. Libraries of 
compound 3D structures are made openly available by chemistry companies, which 
can produce them. Many docking software products are available either open-source 
or licensed. 
3 In silico docking against avian flu 
The first large scale docking experiment focused on virtual screening for neglected 
diseases but new perspectives appear also for using grids to address emerging 
diseases. While the grid added value for neglected diseases is related to their cost 
effectiveness as compared to in vitro testing, grids are also extremely relevant when 
time becomes a critical factor. A collaboration of Asian and European laboratories has 
analyzed 300,000 possible drug compounds against the avian flu virus H5N1 using 
the EGEE Grid infrastructure in April and May 2006 [15]. The goal was to find 
potential compounds that can inhibit the activities of an enzyme on the surface of the 
influenza virus, the so-called neuraminidase, subtype N1. 
3.1 Grid Objective 
Beside the biological goal of reducing time and cost of the initial investment on 
structure-based drug design, there are two Grid technology objectives for this activity: 
one is to improve the performance of the in silico high-throughput screening 
environment based on what has been learnt in the previous challenge against Malaria; 
the other is to test another environment which enables users to have efficient and 
interactive control of the massive molecular dockings on the Grid. Therefore, two 
Grid tools were used in parallel in the second data challenge. An enhanced version of 
WISDOM high-throughput workflow was designed to achieve the first goal and a 
lightweight framework called DIANE [reference] was introduced to carry a 
significant fraction of the deployment for implementing and testing the new scenario. 
3.2 Biological objective 
The potential for re-emergence of influenza pandemics has been a great threat since 
the report that avian influenza A virus (H5N1) could acquire the ability to be 
transmitted to humans. Indeed, an increase of transmission incidents suggests a risk of 
human-to-human transmission [16]. In addition, the report of the development of drug 
resistant variants [17] is of potential concern. Two of the present drugs (oseltamivir 
and zanamivir) were discovered through structure-based drug design targeting 
influenza neuraminidase (NA), a viral enzyme that cleaves terminal sialic acid 
residues from glycoconjugates. The action of NA is essential for virus proliferation 
and infectivity; therefore, blocking its activity generates antivirus effects. To 
minimize non-productive trial-and-error approaches and to accelerate the discovery of 
novel potent inhibitors, medical chemists take advantage of modelled NA variant 
structures and structure-based design. The computational tools for the work are based 
on molecular docking engines to carry out a quick conformational search for small 
compounds in the binding sites, fast calculation of binding energies of possible 
binding poses, prompt selection for the probable binding modes, and precise ranking 
and filtering for good binders. 
4 The grid tools 
4.1 The grid infrastructures 
Compared to WISDOM which used only the EGEE infrastructure, the Avian Flu 
computing challenge used three infrastructures which are sharing the same 
middleware (LCG2) and also common services: Auvergrid, EGEE and TWGrid.  
 Auvergrid (http://www.auvergrid.fr/) is regional grid deployed in the French 
region Auvergne. Its goal is to explore how a grid can provide the resources needed 
for public and private research at a regional level. With more than 800 CPUs available 
at 12 sites, Auvergrid hosts a variety of scientific applications from particle physics to 
life science, environment and chemistry. 
 TWGrid (Taiwan Grid, http://twgrid.org/) is responsible for operating a Grid 
Operation Centre in Asia-Pacific region. Apart from supporting the worldwide Grid 
collaboration in high-energy physics, TWGrid is also in charge of federating and 
coordinating regional Grid resources to promote the Grid technology to the e-Science 
activities (e.g. life science, atmospheric science, digital archive, etc.) in Asia. 
 The EGEE project [3] (Enabling Grid for E-sciencE, http://www.eu-egee.org/) 
brings together experts from over 27 countries with the common aim of building on 
recent advances in Grid technology and developing a service Grid infrastructure 
which is available to scientists 24 hours a day. The project aims to provide researchers 
in academia and industry with access to major computing resources, independent of 
their geographic location. The EGEE infrastructure is now a production grid with a 
large number of applications installed and used on the available resources. The 
infrastructure involves more than 180 sites spread in Europe, America and Asia. The 
two applications described in this paper were deployed within the framework of the 
biomedical Virtual Organization. Resource nodes available for biomedical 
applications scale up to 3,000 CPUs and 21 TB disk space. 
4.2 The WISDOM production environment 
A large-scale deployment requires the development of an environment for job 
submission and output data collection. A number of issues need to be addressed to 
achieve significant acceleration from the grid deployment: 
- Grid performances are impacted by the amount of data moved around at job 
submission. Consequently, the files providing the 3D structure of targets and 
compounds should preferably be stored on grid storage elements in preparation for 
the data challenge. 
- The rate at which jobs are submitted to the grid resource brokers must be carefully 
monitored in order to avoid their overload. The job submission scheme must take 
into account this present limitation of the EGEE brokering system. 
- Grid submission process introduces significant delays for instance at the level of 
resource brokering. The jobs submitted to the grid computing nodes must be 
sufficiently long in order to reduce the impact of this middleware overhead. 
 The WISDOM production environment was designed to achieve production of a 
large amount of data in a limited time using EGEE, Auvergrid and TWGrid 
middleware services. Three packages were developed in Perl and Java. Their entry 
points are a simple command line tool. The first package installs the application 
components (software, compounds database…) on the grid computing nodes. The 
second package tests these components. The third package monitors the submission 
and the execution of the WISDOM jobs. Figure 1 illustrates the packages and the 
steps of the jobs execution. 
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Fig. 1. Design of the WISDOM production system 
 The environment was improved to address limitations and bottlenecks identified 
during the first data challenge against Malaria deployed in the summer of 2005 on the 
EGEE infrastructure. For instance, the number of resource broker machines and the 
rate at which the jobs were submitted to these grid services were reduced to avoid 
their overload. Another improvement concerned the resubmission process after a job 
failure, which was redesigned to avoid “sink-hole” effect on a failing grid-computing 
node. Automatic resubmission was replaced by the manual intervention of the 
WISDOM production user.  
4.3 The DIANE framework 
DIANE (Distributed Analysis Environment, http://cern.ch/diane/) is a lightweight 
distributed framework for parallel scientific applications in master-worker model. It 
assumes that a job may be split into a number of independent tasks, which is a typical 
case in many scientific applications. It has been successfully applied in a number of 
applications ranging from image rendering to data analysis in high-energy physics. 
 As opposed to standard message passing libraries such as MPI [18], the DIANE 
framework takes care of all synchronization, communication and workflow 
management details on behalf of the application. The execution of a job is fully 
controlled by the framework, which decides when and where the tasks are executed. 
Thus the application is very simple to program and contains only the essential code 
directly related to the application itself without bothering about networking details. 
Aiming to efficiently bridge underlying distributed computing environments and 
application centric user interface, DIANE itself is a thin software layer which can 
easily work on top of more fundamental middleware such as LSF, PBS or the Grid 
Resource Brokers. It may also work in a standalone mode and does not require any 
complex underlying software. 
 
 
Fig. 2. Template of DIANE application plug-ins 
As a framework, DIANE provides an adapter for applications. Figure 2 shows the 
template of DIANE application plug-ins. A complete DIANE application plug-in 
should implement three major Python objects: the Planner and the Integrator objects 
implement the job splitting and result merging, respectively; while the logic of the 
Worker object concentrates on the execution of the individual task. When a DIANE 
job is started by a user, both the Planner and the Integrator objects are invoked by a 
master agent usually executed on the user's desktop, and typically the worker agents 
are submitted to run on distributed CPUs such as the Grid worker nodes. 
 Once the worker agent is launched, it first registers itself with the master agent. In 
the second step, a channel is established for pulling the tasks from the queue held by 
the master agent. When the worker agent has finished the individual task, the result is 
returned and merged on the master. The pulling-executing-returning cycle will iterate 
until all the tasks are accomplished. The same channel is also used to profile the 
worker agent's health and to support user interaction with the task. The whole DIANE 
framework is written in Python and the communication between the master agent and 
the worker agents is based on the CORBA protocol. 
5 Results 
5.1 WISDOM results 
The WISDOM experiment ran on the EGEE grid production service from 11 July 
2005 until 19 August 2005. It saw over 46 million docked ligands, the equivalent of 
80 years on a single PC, in about 6 weeks. Up to 1,700 computers were 
simultaneously used in 15 countries around the world. Commercial software with a 
server license was successfully deployed on more than 1,000 machines at the same 
time. WISDOM demonstrated how grid computing can help drug discovery research 
by speeding up the whole process and reduce the cost to develop new drugs to treat 
diseases such as Malaria.  
Grid performances 
The data challenge was a very useful experience to identify the limitations and 
bottlenecks of the EGEE infrastructure. The overall grid efficiency was on average 
about 50%. This means that a large fraction of the jobs had to be resubmitted. This 
generated a significant extra workload for the users.  
 The different sources of failures are identified on table 1 with their corresponding 
rates. 
 In the phase where licensed software was deployed on the grid, the dominant 
origin of failure was the license server in charge of distributing tokens to all the jobs 
running on the grid. The development of a grid service to manage license software is 
under way to address this single point of failure ignored by the information system.  
 The second most important sources of failure were workload management and site 
failures, including overload, disk failure, node mis-configuration, disk space problem, 
air-conditioning and electrical cut. To improve the job submission process, an 
automatic resubmission of jobs was included in the WISDOM execution environment. 
However, the consequence of automatic resubmission was the creation of several 
“sinkhole” effects where all the jobs were attracted to a single node. These sinkhole 
effects were observed when the status of a Computing Element was not correctly 
described in the information system. If a Computing Element already loaded is still 
viewed as completely free by the Information System, it keeps receiving jobs from the 
Resource Broker. If the Computing Element gets down, all jobs are aborted. Even if 
the Computing Element can support the excessive number of jobs, the processing time 
is going to be very long. 
Table 1. Origin of failures during the WISDOM deployment with their corresponding rates 
 Rate Reasons 
Success rate after checking output 
data 
46 %  
Workload Management failure 10 % Overload, Disk failure 
Mis-configuration, disk space problem 
Air-conditioning, power cut 
Data Management failure 4 % Network / connection 
Power cut 
Other unknown causes 
Sites failure 9 % Mis-configuration, Tar command, disk space 
Information system update 
Job number limitation in the waiting queue 
Air-conditioning, Electrical cut 
Unclassified 4 % Lost jobs 
Other unknown causes 
Server license failure 23 % Server failure 
Power cut 
Server stop 
WISDOM failure 4 % Job distribution 
Human error 
Script failure 
 
 The WISDOM production system developed to submit the jobs on the grid 
accounted for a small fraction of the failures, as did also the grid data management 
system. About 1TB of data were produced by the 72,000 jobs submitted. Collection 
and registration of these output data turned out to be a heavy task. The grid data 
management services allowed replicating all the output files for backup. However, 
they did not allow storing all the results directly in a database.  
 Finally, unclassified failures accounted for 4% inefficiency. This illustrates the 
work, which is still needed to improve grid monitoring.  
 In terms of grid throughput, the resource brokers significantly limited the rate at 
which the jobs could be submitted. Another significant source of inefficiency came 
from the difficulty for the grid information system to provide all the relevant 
information to the resource brokers when they distribute the jobs on the grid. 
Therefore, job scheduling was a time-consuming task for the WISDOM users during 
all the data challenge due to the encountered limitations of the information system, 
the computing elements and the resource brokers. The achieved throughput averaged 
about 12 docked ligands per second during the whole computing challenge.  
 Several of the issues identified during WISDOM deployment were improved for 
the second large scale docking targeted on avian flu which is described in the next 
chapter. 
5.2 Results from avian flu computing challenge 
Table 2 summarizes the achieved deployments using WISDOM and DIANE 
environments. 
Table 2. Statistical summary of the WISDOM and DIANE activities 
 WISDOM DIANE 
Total number of completed dockings 2,160,095 308,585 
Estimated duration on 1 CPU 88.3 years 16.7 years 
Duration of the experience 6 weeks 4 weeks 
Cumulative number of Grid jobs 54,000 2,585 
Maximum number of concurrent CPUs 1,700 240 
Number of used Computing Elements 69 36 
Crunching factor 767 203 
Approximated distribution efficiency 46% 84% 
 
 During the avian flu computing challenge, the WISDOM production environment 
was used to distribute 54,000 jobs on 69 Grid Computing Elements to dock about 2 
million pairs of target and chemical compound for a total amount of about 88 CPU 
years. Because the Grid resources were used by other virtual organizations during the 
data challenge, a maximum of 1,700 CPUs were concurrently running at the same 
time. For the DIANE part, we were able to complete 308,585 docking runs (i.e. 1/8 of 
the whole challenge) in 30 days using the computing resources of 36 Grid nodes. A 
total number of 2,580 DIANE worker agents have been running as Grid jobs during 
that the DIANE master concurrently maintained period and 240 of them. About 750 
GBytes of date have been produced on the Grid during the data challenge. 
Grid performances 
Since a Grid is a dynamic system in which the status of resources may change without 
central control, transient problems occur which cause job failures. In the WISDOM 
activity, about 83% of the jobs were reported as successfully finished according to the 
status logged in the Grid Logging and Bookkeeping system; the observed failures 
were mainly due to errors at job scheduling time because of mis-configuration of Grid 
Computing Elements. However, the success rate went down to 80% after checking the 
content of the data output file and subtracting human failures. The main cause for 
these failures was frequent last-minute error in the transfer of results to the Grid 
Storage Elements. Compared to the previous data challenge, improvement is 
significant as the observed success rates were respectively 77 and 63%. The last-
minute error in output data transfer is particularly expensive since the results are no 
longer available on the Grid Worker Node although they might have been 
successfully produced. 
 In DIANE, a similar job failure rate was also observed; nevertheless, the failure 
recovery mechanism in DIANE automated the re-submission and guaranteed a finally 
fully complete job. On the other hand, the feature of interactively returning part of the 
computing efforts during the runtime (e.g. the output of each docking) also introduces 
a more economical way in using the Grid resources.  
 For the instances submitted using WISDOM production environment, the overall 
crunching factor was about 767. The corresponding distribution efficiency defined as 
the ratio between the overall crunching factor and the maximum number of 
concurrently running CPUs was estimated to 46%. This is due to the known issue of 
long job waiting time in current EGEE production system.  
 The task pull model adopted by DIANE allows isolating the scheduling overhead 
of the Grid jobs and is therefore expected to achieve a better distribution efficiency. 
During the data challenge, DIANE was able to push the efficiency to higher than 80% 
within the scope of handling intermediate scale of distributed docking. A fare 
comparison with WISDOM can only be made if the improvement of the DIANE 
framework is tested in a large scale as the exercise of WISDOM. Because of the 
highly scalable nature of the WISDOM framework, high throughput docking could be 
achieved at a rate of 2 seconds per docking. As DIANE was handling not more than a 
few hundred concurrent jobs, its throughput was limited to about one docking every 9 
seconds. The difference observed between the throughputs achieved during the 
WISDOM and avian flu computing challenges is because each docking computation 
was very significantly longer during the avian flu data challenge. 
6 Perspectives 
The results obtained by the first two virtual docking computing challenges have 
opened important perspectives. On the grid side, developments are under way to 
further improve the WISDOM and DIANE environments to improve the quality of 
service offered to the end users. From an application point of view, beyond the 
necessity to analyze the results obtained on Malaria and avian flu, it is particularly 
relevant to further enable the deployment of virtual screening on large-scale grids.  
6.1 Perspective on the grid side: WISDOM-II 
The impact of the first WISDOM computing challenge has significantly raised the 
interest of the research community on neglected diseases so that several laboratories 
all around the world have expressed interest to propose targets for a second 
computing challenge called WISDOM-II. Contacts have been established with 
research groups from Italy, United Kingdom, Venezuela, South Africa and Thailand 
and discussions are under way to finalize the list of targets to be docked. 
 As well, several grid projects have expressed interest to contribute to the 
WISDOM initiative by providing computing resources (Auvergrid, EELA 
(http://www.eu-eela.org/), Southeast Asia Grid, Swiss Biogrid 
(http://www.swissbiogrid.com/)) or by contributing to the development of the virtual 
screening pipeline (Embrace (http://www.embracegrid.info/), BioinfoGRID 
(http://www.bioinfogrid.eu/)). Of particular interest for WISDOM-II is the 
deployment of a common application on several infrastructures using different 
middlewares like EGEE and Swiss Biogrid. 
6.2 From virtual docking to virtual screening 
While docking methods have been significantly improved in the last years, it is 
general opinion that docking results need to be post-processed with more accurate 
modelling tools before biological tests are undertaken, such as Molecular dynamics 
(MD). However, for the same number of compounds, MD analysis requires much 
heavier computing than docking. Consequently, MD can only be applied to a 
restricted number of compounds, usually the best hits coming out of the docking step. 
MD and subsequent free-energy analysis most often changes significantly the scoring 
of the best compounds and it is therefore very important to apply it to as many 
compounds as possible. Grids appear very promising to improve the virtual screening 
process by increasing the number of compounds that will be processed using MD. 
 For instance, running MD analysis with Amber 8 software on 1 protein target and 
10,000 compounds requires about 50 CPU years for a model with few thousands 
atoms and few 10,000s of steps. This process produces only 10s GB of data. One run 
with only one compound takes 44 hours (computing time heavily depends on choice 
of conditions, like explicit water simulations, or generalized born simulations). 
 Both grids of clusters such as EGEE and grids of supercomputers such as DEISA 
(http://www.deisa.org/) are relevant for MD computing. MD computations of large 
molecules are significantly faster on a supercomputer. Within the framework of the 
BioinfoGRID European project, focus will be put on the reranking of the best scoring 
ligands coming out of WISDOM. The goal will be to deploy on at least one of the 
European grid infrastructures MD software to rerank the best compounds before in 
vitro testing.  
7 Conclusion  
Large-scale grids offer unprecedented perspectives for in silico drug discovery. This 
paper has presented pioneering activities in the field of grid enabled virtual screening 
against neglected and emerging diseases in Europe. This activity started with a large 
scale docking deployment against Malaria on the EGEE infrastructure in 2005, which 
was followed by another computing challenge focused on avian flu in the spring of 
2006. A second computing challenge on neglected diseases is foreseen to take place 
in the fall: it will involve several European projects, which bring additional resources 
and complementary contributions in order to enable the complete virtual screening 
process on the grid. 
 These deployments were achieved using two different systems for submission and 
monitoring of virtual docking jobs. The WISDOM system was designed to achieve 
production of a large amount of data in a limited time while the DIANE framework 
was designed as a lightweight distributed framework for parallel scientific 
applications in master-worker model. Both systems were able to provide high 
throughput virtual docking. The DIANE framework demonstrated better 
performances in terms of job success while the WISDOM system allowed to achieve 
higher throughput. Development of a new system merging functionalities from both 
WISDOM and DIANE frameworks is under way in the perspective of WISDOM-II, 
second computing challenge on neglected diseases. 
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